isoproterenol has been researched along with Tachycardia, Ventricular in 109 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients." | 7.88 | Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018) |
| "To test this hypothesis, we studied the effect of isoproterenol on accessory pathway function and tachycardia induction in 18 patients (12 men and 6 women, ages 34 +/- 16 years [mean +/- SD]) with UACAP." | 5.08 | Effect of isoproterenol on accessory pathways without overt retrograde conduction. ( Klein, GJ; Li, HG; Yee, R, 1995) |
| "To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients." | 3.88 | Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018) |
| " All 12 symptomatic patients and 1 asymptomatic sibling (mean age, 13+/-7 years) were found to have a relative resting bradycardia (64+/-13 bpm, versus 93+/-12 bpm in the unaffected siblings), as well as PVT induced by treadmill or isoproterenol infusion and appearing at a mean sinus rate of 110+/-10 bpm." | 3.71 | Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. ( Bahan, T; Eldar, M; Friedman, E; Goldman, B; Kastner, DL; Khoury, A; Lahat, H; Levy-Nissenbaum, E; Lorber, A; Pras, E, 2001) |
| "The frequency-dependent electrophysiologic effects of sematilide (n = 11) and amiodarone (n = 22) were determined at (1) drug-free baseline, (2) during steady-state (> 48 hours) dosing with sematilide (455 +/- 5 mg/d [mean +/- SEM]) or after 10." | 2.67 | The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. ( Follmer, C; Godfrey, R; Pruitt, C; Sager, PT; Uppal, P, 1994) |
| "In 6 patients, arrhythmias were controlled after extracorporeal membrane oxygenation (ECMO) support; 5 of these patients survived." | 1.72 | Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. ( Azamian, M; Beach, CM; Ceresnak, SR; Delauz, CM; Ehsan, SA; Glinton, KE; Houck, KM; Howard, TS; Janson, CM; Jardine, K; Kannankeril, PJ; Kava, M; Kim, JJ; Lalani, SR; Lay, EJ; Li, N; Liberman, L; Macicek, SL; Milewicz, DM; Miyake, CY; Pham, TD; Robertson, T; Soler-Alfonso, C; Stephens, SB; Tosur, M; Valdes, SO; Webster, G; Xu, W; Zhang, L, 2022) |
| "To our knowledge, presentation of ventricular tachycardia caused by primary hyperparathyroidism in such a young patient has not been reported in medical literature so far." | 1.48 | Ventricular tachycardia in a 16-year-old boy with primary hyperparathyroidism. ( Dilber, D; Marčinković, N; Velagić, V, 2018) |
| "We aimed to elucidate arrhythmia mechanisms in a RyR2-linked CPVT mutation (RyR2-A4860G) that depresses channel activity." | 1.42 | Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function. ( Gurrola, GB; Jalife, J; Moss, RL; Powers, PP; Valdivia, CR; Valdivia, HH; Willis, BC; Zhao, YT, 2015) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion." | 1.42 | Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. ( Arad, M; Barad, L; Binah, O; Eisen, B; Eldar, M; Eldor, L; Gherghiceanu, M; Itskovitz-Eldor, J; Lorber, A; Novak, A; Reiter, I, 2015) |
| "Exercise-related ventricular tachycardia (VT) and high burden of premature ventricular contractions (PVCs) are common in arrhythmogenic right ventricular dysplasia/cardiomyopathy." | 1.39 | High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. ( Bhonsale, A; Calkins, H; James, C; Laurita, KR; Madhavan, S; Murray, B; Nazarian, S; Needleman, M; Philips, B; Tandri, H; Tichnell, C, 2013) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes." | 1.39 | Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. ( Faggioni, M; Hwang, HS; Kannankeril, PJ; Knollmann, BC; Nederend, I; van der Werf, C; Wilde, AA, 2013) |
| "We also observed polymorphic ventricular tachycardia in the CASQ2(D307H) mice, although lesser than in the CASQ2 null mice." | 1.38 | Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background. ( Belevych, AE; Gyorke, S; Hwang, HS; Kalyanasundaram, A; Knollmann, BC; Lacombe, VA; Periasamy, M; Viatchenko-Karpinski, S, 2012) |
| "Catecholaminergic polymorphic ventricular tachycardia is characterized by stress-triggered syncope and sudden death." | 1.38 | Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia. ( Benitah, JP; Gómez, AM; Liu, N; Mangoni, ME; Mesirca, P; Napolitano, C; Neco, P; Priori, SG; Richard, S; Torrente, AG; Zorio, E, 2012) |
| "In some patients with clinical paroxysmal supraventricular tachycardia (PSVT), who are candidates for radiofrequency (RF) catheter ablation, attempts for the induction of arrhythmia during the electrophysiological study (EPS) fail despite different stimulation protocols even during the isoproterenol infusion and atropine injection." | 1.37 | A new method for induction of atrioventricular nodal reentrant tachycardia in non-inducible cases. ( Davoodi, GR; Fakhrzadeh, H; Ghazanchai, F; Kazemisaeid, A; Vasheghani Farahani, A; Yamini Sharif, A, 2011) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2." | 1.36 | Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. ( Doi, M; Ikeda, Y; Ikemoto, N; Kobayashi, S; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Ono, M; Suetomi, T; Tateishi, H; Uchinoumi, H; Xu, X; Yamamoto, T; Yano, M, 2010) |
| "We describe a 71-year-old man with a ventricular tachycardia (VT) originating from the mitral annulus." | 1.33 | Idiopathic ventricular tachycardia originating from the posteroseptal mitral annulus: a case report. ( Ashikaga, K; Tashiro, H; Tsuchiya, T; Yamamoto, K, 2006) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an autosomal dominant inherited disorder characterized by adrenergic induced polymorphic ventricular tachycardias and associated with sudden cardiac death." | 1.33 | A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia. ( Aizawa, Y; Chinushi, M; Hayashi, T; Hiraoka, M; Inagaki, N; Kimura, A; Komura, S; Matsumoto, Y; Nakano, N; Takahashi, M; Ueda, K; Washizuka, T; Yasunami, M, 2005) |
| "Although catecholaminergic polymorphic ventricular tachycardia (CPVT) is associated with fatal ventricular arrhythmias and sudden death, the ECG findings are not fully understood." | 1.33 | Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). ( Aizawa, Y; Chinushi, M; Komura, S; Morita, H; Ohe, T; Okada, S, 2006) |
| "Ventricular arrhythmias can cause sudden cardiac death (SCD) in patients with normal hearts and in those with underlying disease such as heart failure." | 1.32 | Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. ( Cervantes, D; Coromilas, J; Deng, SX; Landry, DW; Lehnart, SE; Marks, AR; Reiken, SR; Vest, JA; Wehrens, XH, 2004) |
| "Ventricular tachyarrhythmias were initiated in TG mice by programmed stimulation but not in WT and were accelerated by isoproterenol." | 1.32 | Electrophysiological consequences of human IKs channel expression in adult murine heart. ( Cabo, C; Chiello Tracy, C; Coromilas, J; Kass, RS; Kurokawa, J; Wit, AL, 2003) |
| "Exercise test-induced ventricular tachycardia was nonsustained in 17 patients and sustained in 2 cases." | 1.31 | Adrenergic nervous system influences on the induction of ventricular tachycardia. ( Beloscar, JS; Mariani, E; Pellizzón, OA, 2002) |
| "13 patients whose ventricular tachycardia was treated with RF ablation were followed up more than 18 months after RF ablation." | 1.30 | Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome. ( Aizawa, Y; Chinushi, M; Kitazawa, H; Shibata, A; Takahashi, K, 1997) |
| "Supraventricular tachyarrhythmias (SVTA) may occur in patients with the arrhythmogenic right ventricular dysplasia (ARVD)." | 1.30 | Increased atrial vulnerability in arrhythmogenic right ventricular disease. ( Berder, V; Beurrier, D; Brembilla-Perrot, B; Houplon, P; Houriez, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A, 1998) |
| "Therefore, in patients with idiopathic ventricular tachycardia, even if the induction of tachycardia requires infusion of isoproterenol, successful pace mapping may be performed in its absence." | 1.30 | Effect of isoproterenol on QRS complex morphology during ventricular pacing: implications for pace mapping. ( Bahu, M; Daoud, EG; Goyal, R; Knight, BP; Man, KC; Morady, F; Mukhopadhyay, PS; Strickberger, SA; Syed, ZA; Weiss, R, 1998) |
| "Isoproterenol was administered as a loading dosage of 0." | 1.30 | Use-dependent electrophysiologic effects of DL-sotalol and modulation by isoproterenol in the human ventricle. ( Aizawa, Y; Furushima, H; Naitoh, N; Ohira, K; Taneda, K, 1998) |
| "During isoprenaline infusion, ventricular tachycardia originating from the right ventricular outflow tract (RVOT) with a cycle length of 280 ms was induced and subsequently atrioventricular reentrant tachycardia (AVRT) with a cycle length of 300 ms using an accessory pathway in the left free wall appeared." | 1.30 | AV reentrant and idiopathic ventricular double tachycardias: complicated interactions between two tachycardias. ( Aizawa, Y; Niwano, S; Tsuchida, K; Washizuka, T, 1999) |
| "5+/-4, p = 0." | 1.30 | Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy. ( Aizawa, Y; Izumi, T; Kitano, Y; Moriguchi, M; Niwano, S; Yamaura, M; Yoshizawa, N, 1999) |
| "Sustained ventricular tachycardia with right bundle branch block morphology and left- or right-axis deviation was documented in all patients." | 1.29 | Idiopathic left ventricular tachycardia: new insights into electrophysiological characteristics and radiofrequency catheter ablation. ( Borggrefe, M; Breithardt, G; Chen, X; Haverkamp, W; Hindricks, G; Kottkamp, H; Wichter, T; Willems, S, 1995) |
| "The site of the origin of ventricular tachycardia was localized in the right ventricular outflow tract in both cases." | 1.29 | [Catheter ablation of tachycardia of the outlet right ventricle using radiofrequency as power source]. ( Balbão, CE; da Silva, RM; de Paola, AA; Hara, VM; Martinez Filho, EE; Mendonça, A; Netto, Oda S; Portugal, OP; Tavora, MZ, 1993) |
| "Syncope associated with paroxysmal atrial fibrillation has been interpreted as an ominous finding predictive of rapid ventricular rates." | 1.29 | Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation. ( Bottoni, N; Brignole, M; Gianfranchi, L; Lolli, G; Menozzi, C; Oddone, D; Raviele, A, 1993) |
| "Isoproterenol infusion was required for tachycardia induction in 50% of patients, 44% of whom had VT with a left bundle branch block QRS pattern, with the remaining 56% exhibiting VT with a right bundle branch block pattern." | 1.29 | Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease. ( Chun, H; Lai, WT; Lauer, MR; Lee, KL; Liem, LB; Sung, RJ; Tai, YT; Young, C, 1996) |
| "The diagnosis of ventricular tachycardia could therefore be continued." | 1.29 | [Should protocol of programmed ventricular stimulation be adapted to each patient? ]. ( Brembilla-Perrot, B; Houplon, P; Jacquemin, L; Lemoine, C; Mathieu, P, 1996) |
| "Polymorphic arrhythmia occurred in 80% of cases, but left lag forms predominated." | 1.28 | [Complementary value of the isoprenaline test and high-amplification ECG in the diagnosis of arrhythmogenic dysplasia of the right ventricle]. ( Barat, JL; Chavernac, P; Haissaguerre, M; Héraudeau, A; Le Métayer, P; Montserrat, P; Warin, JF, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (4.59) | 18.7374 |
| 1990's | 30 (27.52) | 18.2507 |
| 2000's | 36 (33.03) | 29.6817 |
| 2010's | 35 (32.11) | 24.3611 |
| 2020's | 3 (2.75) | 2.80 |
| Authors | Studies |
|---|---|
| Aras, K | 1 |
| Gams, A | 1 |
| Faye, NR | 1 |
| Brennan, J | 1 |
| Goldrick, K | 1 |
| Li, J | 1 |
| Zhong, Y | 1 |
| Chiang, CH | 1 |
| Smith, EH | 1 |
| Poston, MD | 1 |
| Chivers, J | 1 |
| Hanna, P | 1 |
| Mori, S | 1 |
| Ajijola, OA | 1 |
| Shivkumar, K | 1 |
| Hoover, DB | 1 |
| Viventi, J | 1 |
| Rogers, JA | 1 |
| Bernus, O | 1 |
| Efimov, IR | 1 |
| Miyake, CY | 1 |
| Lay, EJ | 1 |
| Beach, CM | 1 |
| Ceresnak, SR | 2 |
| Delauz, CM | 1 |
| Howard, TS | 1 |
| Janson, CM | 1 |
| Jardine, K | 1 |
| Kannankeril, PJ | 3 |
| Kava, M | 1 |
| Kim, JJ | 1 |
| Liberman, L | 1 |
| Macicek, SL | 1 |
| Pham, TD | 1 |
| Robertson, T | 1 |
| Valdes, SO | 1 |
| Webster, G | 1 |
| Stephens, SB | 1 |
| Milewicz, DM | 1 |
| Azamian, M | 1 |
| Ehsan, SA | 1 |
| Houck, KM | 1 |
| Soler-Alfonso, C | 1 |
| Glinton, KE | 1 |
| Tosur, M | 1 |
| Li, N | 2 |
| Xu, W | 1 |
| Lalani, SR | 1 |
| Zhang, L | 1 |
| Mollenhauer, M | 1 |
| Mehrkens, D | 1 |
| Klinke, A | 1 |
| Lange, M | 1 |
| Remane, L | 1 |
| Friedrichs, K | 1 |
| Braumann, S | 1 |
| Geißen, S | 1 |
| Simsekyilmaz, S | 1 |
| Nettersheim, FS | 1 |
| Lee, S | 1 |
| Peinkofer, G | 1 |
| Geisler, AC | 1 |
| Geis, B | 1 |
| Schwoerer, AP | 1 |
| Carrier, L | 1 |
| Freeman, BA | 1 |
| Dewenter, M | 1 |
| Luo, X | 1 |
| El-Armouche, A | 1 |
| Wagner, M | 1 |
| Adam, M | 1 |
| Baldus, S | 1 |
| Rudolph, V | 1 |
| Denis, A | 2 |
| Sacher, F | 2 |
| Derval, N | 2 |
| Martin, R | 1 |
| Lim, HS | 1 |
| Pambrun, T | 1 |
| Massoullie, G | 1 |
| Duchateau, J | 1 |
| Cochet, H | 2 |
| Pillois, X | 2 |
| Cheniti, G | 1 |
| Frontera, A | 2 |
| Takigawa, M | 1 |
| Vlachos, K | 1 |
| Martin, C | 1 |
| Kitamura, T | 1 |
| Hocini, M | 2 |
| Douard, H | 1 |
| Jaïs, P | 2 |
| Haïssaguerre, M | 3 |
| Marinheiro, R | 1 |
| Parreira, L | 1 |
| Amador, P | 1 |
| Sardinha, F | 1 |
| Gonçalves, S | 1 |
| Serra, S | 1 |
| Marčinković, N | 1 |
| Dilber, D | 1 |
| Velagić, V | 1 |
| Wang, Y | 2 |
| Patel, D | 1 |
| Wang, DW | 2 |
| Yan, JT | 1 |
| Hsia, HH | 1 |
| Liu, H | 1 |
| Zhao, CX | 1 |
| Zuo, HJ | 1 |
| Bai, Y | 1 |
| Jones, PP | 1 |
| Guo, J | 1 |
| Zhong, X | 1 |
| Clark, RB | 1 |
| Zhou, Q | 1 |
| Wang, R | 1 |
| Vallmitjana, A | 1 |
| Benitez, R | 1 |
| Hove-Madsen, L | 1 |
| Semeniuk, L | 1 |
| Guo, A | 1 |
| Song, LS | 1 |
| Duff, HJ | 1 |
| Chen, SR | 1 |
| Nayyar, S | 1 |
| Roberts-Thomson, KC | 1 |
| Hasan, MA | 1 |
| Sullivan, T | 1 |
| Harrington, J | 1 |
| Sanders, P | 1 |
| Baumert, M | 1 |
| Maury, P | 1 |
| Hascoët, S | 1 |
| Mondoly, P | 1 |
| Acar, P | 1 |
| Fukuda, M | 1 |
| Yamamoto, T | 2 |
| Nishimura, S | 1 |
| Kato, T | 1 |
| Murakami, W | 1 |
| Hino, A | 1 |
| Ono, M | 2 |
| Tateishi, H | 2 |
| Oda, T | 2 |
| Okuda, S | 2 |
| Kobayashi, S | 2 |
| Koseki, N | 1 |
| Kyushiki, H | 1 |
| Yano, M | 2 |
| Tsui, H | 1 |
| Ke, Y | 1 |
| Shi, Y | 1 |
| Li, Y | 1 |
| Davies, L | 1 |
| Cartwright, EJ | 1 |
| Venetucci, L | 1 |
| Zhang, H | 1 |
| Terrar, DA | 1 |
| Huang, CL | 3 |
| Solaro, RJ | 1 |
| Wang, X | 1 |
| Lei, M | 1 |
| Zhao, YT | 1 |
| Valdivia, CR | 1 |
| Gurrola, GB | 1 |
| Powers, PP | 1 |
| Willis, BC | 1 |
| Moss, RL | 1 |
| Jalife, J | 1 |
| Valdivia, HH | 1 |
| Tsai, WC | 1 |
| Lu, YY | 1 |
| Chen, YC | 1 |
| Chang, CJ | 1 |
| Kao, YH | 1 |
| Lin, YK | 1 |
| Chen, YH | 1 |
| Chen, SA | 1 |
| Yang, LY | 1 |
| Chen, YJ | 1 |
| Gopi, A | 1 |
| Nair, SG | 1 |
| Shelke, A | 1 |
| Saggu, DK | 1 |
| Yalagudri, S | 1 |
| Reddy, P | 1 |
| Narasimhan, C | 1 |
| Novak, A | 2 |
| Barad, L | 2 |
| Lorber, A | 3 |
| Gherghiceanu, M | 1 |
| Reiter, I | 1 |
| Eisen, B | 1 |
| Eldor, L | 1 |
| Itskovitz-Eldor, J | 2 |
| Eldar, M | 2 |
| Arad, M | 1 |
| Binah, O | 2 |
| Berte, B | 1 |
| Amraoui, S | 1 |
| Yamashita, S | 1 |
| Komatsu, Y | 1 |
| Mahida, S | 1 |
| Wielandts, JY | 1 |
| Sellal, JM | 1 |
| Al Jefairi, N | 1 |
| Montaudon, M | 1 |
| Laurent, F | 1 |
| Liu, B | 1 |
| Ho, HT | 1 |
| Brunello, L | 1 |
| Unudurthi, SD | 1 |
| Lou, Q | 1 |
| Belevych, AE | 2 |
| Qian, L | 1 |
| Kim, DH | 1 |
| Cho, C | 1 |
| Janssen, PM | 1 |
| Hund, TJ | 1 |
| Knollmann, BC | 5 |
| Kranias, EG | 1 |
| Györke, S | 3 |
| Ferrantini, C | 1 |
| Coppini, R | 1 |
| Scellini, B | 1 |
| Ferrara, C | 1 |
| Pioner, JM | 1 |
| Mazzoni, L | 1 |
| Priori, S | 1 |
| Cerbai, E | 1 |
| Tesi, C | 1 |
| Poggesi, C | 1 |
| Paavola, J | 1 |
| Väänänen, H | 1 |
| Larsson, K | 1 |
| Penttinen, K | 1 |
| Toivonen, L | 1 |
| Kontula, K | 1 |
| Laine, M | 1 |
| Aalto-Setälä, K | 1 |
| Swan, H | 1 |
| Viitasalo, M | 1 |
| Patocskai, B | 1 |
| Barajas-Martinez, H | 1 |
| Hu, D | 1 |
| Gurabi, Z | 1 |
| Koncz, I | 1 |
| Antzelevitch, C | 2 |
| Sasaki, K | 1 |
| Makiyama, T | 1 |
| Yoshida, Y | 1 |
| Wuriyanghai, Y | 1 |
| Kamakura, T | 1 |
| Nishiuchi, S | 1 |
| Hayano, M | 1 |
| Harita, T | 1 |
| Yamamoto, Y | 1 |
| Kohjitani, H | 1 |
| Hirose, S | 1 |
| Chen, J | 1 |
| Kawamura, M | 2 |
| Ohno, S | 1 |
| Itoh, H | 1 |
| Takeuchi, A | 1 |
| Matsuoka, S | 1 |
| Miura, M | 1 |
| Sumitomo, N | 2 |
| Horie, M | 2 |
| Yamanaka, S | 1 |
| Kimura, T | 1 |
| Beyer, A | 1 |
| Ganti, B | 1 |
| Majkrzak, A | 1 |
| Theyyunni, N | 1 |
| Hothi, SS | 1 |
| Gurung, IS | 1 |
| Heathcote, JC | 1 |
| Zhang, Y | 1 |
| Booth, SW | 1 |
| Skepper, JN | 1 |
| Grace, AA | 2 |
| Allocca, G | 1 |
| Proclemer, A | 1 |
| Nucifora, G | 1 |
| Dall'Armellina, E | 1 |
| Rebellato, L | 1 |
| Atiyeh, RH | 1 |
| Arthur, ME | 1 |
| Berman, AE | 1 |
| Castresana, MR | 1 |
| Roten, L | 1 |
| Tanner, H | 1 |
| Fernández-Velasco, M | 2 |
| Rueda, A | 1 |
| Rizzi, N | 1 |
| Benitah, JP | 3 |
| Colombi, B | 1 |
| Napolitano, C | 4 |
| Priori, SG | 4 |
| Richard, S | 3 |
| Gómez, AM | 3 |
| Jastrzebski, M | 1 |
| Uchinoumi, H | 1 |
| Suetomi, T | 1 |
| Xu, X | 1 |
| Doi, M | 1 |
| Ikeda, Y | 1 |
| Ohkusa, T | 1 |
| Ikemoto, N | 1 |
| Matsuzaki, M | 1 |
| Yiu, KH | 1 |
| Tse, HF | 1 |
| Lau, CP | 1 |
| Kashimura, T | 1 |
| Briston, SJ | 1 |
| Trafford, AW | 1 |
| Eisner, DA | 1 |
| Venetucci, LA | 1 |
| Ye, L | 1 |
| Zhu, W | 1 |
| Backx, PH | 1 |
| Cortez, MA | 1 |
| Wu, J | 1 |
| Chow, YH | 1 |
| McKerlie, C | 1 |
| Wang, A | 1 |
| Tsui, LC | 1 |
| Gross, GJ | 1 |
| Hu, J | 1 |
| Pass, RH | 1 |
| Liu, N | 2 |
| Denegri, M | 1 |
| Ruan, Y | 1 |
| Avelino-Cruz, JE | 1 |
| Perissi, A | 1 |
| Negri, S | 1 |
| Coetzee, WA | 1 |
| Boyden, PA | 1 |
| Yamini Sharif, A | 1 |
| Vasheghani Farahani, A | 1 |
| Davoodi, GR | 1 |
| Kazemisaeid, A | 1 |
| Fakhrzadeh, H | 1 |
| Ghazanchai, F | 1 |
| Ashikaga, K | 1 |
| Tsuchiya, T | 1 |
| Tashiro, H | 1 |
| Yamamoto, K | 1 |
| Page, SP | 1 |
| Pfeffer, C | 1 |
| Schilling, RJ | 1 |
| Sporton, SC | 1 |
| Kalyanasundaram, A | 2 |
| Viatchenko-Karpinski, S | 2 |
| Lacombe, VA | 2 |
| Hwang, HS | 2 |
| Periasamy, M | 2 |
| Zeevi-Levin, N | 1 |
| Shick, R | 1 |
| Shtrichman, R | 1 |
| Johnson, CM | 1 |
| Pogwizd, SM | 1 |
| Neco, P | 1 |
| Torrente, AG | 1 |
| Mesirca, P | 1 |
| Zorio, E | 1 |
| Mangoni, ME | 1 |
| Qin, M | 1 |
| Liu, T | 1 |
| Hu, H | 1 |
| Wang, T | 1 |
| Yu, S | 1 |
| Huang, C | 1 |
| Philips, B | 1 |
| Madhavan, S | 1 |
| James, C | 1 |
| Tichnell, C | 1 |
| Murray, B | 1 |
| Needleman, M | 1 |
| Bhonsale, A | 1 |
| Nazarian, S | 1 |
| Laurita, KR | 2 |
| Calkins, H | 1 |
| Tandri, H | 1 |
| Faggioni, M | 1 |
| van der Werf, C | 1 |
| Nederend, I | 1 |
| Wilde, AA | 1 |
| Chiello Tracy, C | 1 |
| Cabo, C | 1 |
| Coromilas, J | 2 |
| Kurokawa, J | 1 |
| Kass, RS | 1 |
| Wit, AL | 1 |
| Pellizzón, OA | 1 |
| Beloscar, JS | 1 |
| Mariani, E | 1 |
| Odashiro, K | 1 |
| Hiramatsu, S | 1 |
| Yanagi, N | 1 |
| Arita, T | 1 |
| Maruyama, T | 1 |
| Kaji, Y | 1 |
| Harada, M | 1 |
| Kirchhof, P | 1 |
| Sirenko, SG | 1 |
| Degen, H | 1 |
| Greene, AE | 1 |
| Schober, T | 1 |
| Mackow, JC | 1 |
| Fabritz, L | 1 |
| Potter, JD | 1 |
| Morad, M | 1 |
| George, CH | 1 |
| Higgs, GV | 1 |
| Lai, FA | 1 |
| Obreztchikova, MN | 1 |
| Sosunov, EA | 2 |
| Anyukhovsky, EP | 1 |
| Moïse, NS | 2 |
| Robinson, RB | 1 |
| Rosen, MR | 2 |
| LINENTHAL, AJ | 1 |
| ZOLL, PM | 1 |
| UNDERHILL, WL | 1 |
| TREDWAY, JB | 1 |
| PINAR, S | 1 |
| SCHUERHOLZ, K | 1 |
| FOLDENAUER, A | 1 |
| STUMPF, P | 1 |
| BOEHM, P | 1 |
| MATTHEWS, RJ | 1 |
| Wehrens, XH | 1 |
| Lehnart, SE | 1 |
| Reiken, SR | 1 |
| Deng, SX | 1 |
| Vest, JA | 1 |
| Cervantes, D | 1 |
| Landry, DW | 1 |
| Marks, AR | 1 |
| Balasubramaniam, R | 1 |
| Chawla, S | 1 |
| Mackenzie, L | 1 |
| Schwiening, CJ | 1 |
| Katra, RP | 1 |
| Aizawa, Y | 10 |
| Ueda, K | 1 |
| Komura, S | 2 |
| Washizuka, T | 2 |
| Chinushi, M | 4 |
| Inagaki, N | 1 |
| Matsumoto, Y | 1 |
| Hayashi, T | 2 |
| Takahashi, M | 1 |
| Nakano, N | 1 |
| Yasunami, M | 1 |
| Kimura, A | 1 |
| Hiraoka, M | 3 |
| Nam, GB | 1 |
| Burashnikov, A | 1 |
| Komiya, N | 1 |
| Seto, S | 1 |
| Nakao, K | 1 |
| Yano, K | 1 |
| Topilski, I | 1 |
| Glick, A | 1 |
| Viskin, S | 1 |
| Belhassen, B | 1 |
| Hayashi, M | 1 |
| Okazaki, H | 1 |
| Igei, S | 1 |
| Inada, K | 1 |
| Matuo, S | 1 |
| Date, T | 1 |
| Yagi, H | 1 |
| Yamane, T | 1 |
| Sugimoto, K | 1 |
| Mochizuki, S | 1 |
| Okada, S | 1 |
| Morita, H | 1 |
| Ohe, T | 1 |
| Dirksen, WP | 1 |
| Chi, M | 1 |
| Terentyev, D | 1 |
| Zhou, Z | 1 |
| Vedamoorthyrao, S | 1 |
| Chiamvimonvat, N | 1 |
| Carnes, CA | 1 |
| Franzini-Armstrong, C | 2 |
| Faber, GM | 1 |
| Rudy, Y | 1 |
| Joshi, S | 1 |
| Raiszadeh, F | 1 |
| Pierce, W | 1 |
| Steinberg, JS | 1 |
| Chopra, N | 1 |
| Yang, T | 1 |
| Hlaing, T | 1 |
| Holinstat, I | 1 |
| Ettensohn, K | 1 |
| Pfeifer, K | 1 |
| Akin, B | 1 |
| Jones, LR | 1 |
| Yamawake, N | 1 |
| Nishizaki, M | 1 |
| Niki, S | 1 |
| Maeda, S | 1 |
| Tanaka, Y | 1 |
| Fujii, H | 1 |
| Ashikaga, T | 1 |
| Sakurada, H | 2 |
| Shannon, TR | 1 |
| Taniguchi, K | 1 |
| Matsumura, M | 1 |
| Abe, O | 1 |
| Miyashita, M | 1 |
| Kanamaru, H | 1 |
| Karasawa, K | 1 |
| Ayusawa, M | 1 |
| Fukamizu, S | 1 |
| Nagaoka, I | 1 |
| Harada, K | 1 |
| Galindo-Tovar, A | 1 |
| Kaumann, AJ | 1 |
| Gellen, B | 1 |
| Briec, F | 1 |
| Vinet, L | 1 |
| LeQuang, K | 1 |
| Rouet-Benzineb, P | 1 |
| Pezet, M | 1 |
| Palais, G | 1 |
| Pellegrin, N | 1 |
| Zhang, A | 1 |
| Perrier, R | 1 |
| Escoubet, B | 1 |
| Marniquet, X | 1 |
| Jaisser, F | 1 |
| Charpentier, F | 1 |
| Mercadier, JJ | 1 |
| Wienecke, M | 1 |
| Case, C | 1 |
| Buckles, D | 1 |
| Gillette, P | 1 |
| Kobayashi, Y | 2 |
| Kikushima, S | 1 |
| Tanno, K | 1 |
| Kurano, K | 1 |
| Baba, T | 1 |
| Katagiri, T | 2 |
| Mittleman, RS | 1 |
| Candinas, R | 1 |
| Collett-Willey, P | 1 |
| Huang, SK | 1 |
| Li, HG | 1 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Kottkamp, H | 1 |
| Chen, X | 1 |
| Hindricks, G | 1 |
| Willems, S | 1 |
| Haverkamp, W | 1 |
| Wichter, T | 1 |
| Breithardt, G | 1 |
| Borggrefe, M | 1 |
| Sager, PT | 2 |
| Follmer, C | 1 |
| Uppal, P | 1 |
| Pruitt, C | 1 |
| Godfrey, R | 1 |
| Ng, KS | 1 |
| Wen, MS | 1 |
| Yeh, SJ | 1 |
| Lin, FC | 1 |
| Wu, D | 1 |
| de Paola, AA | 1 |
| Netto, Oda S | 1 |
| Balbão, CE | 1 |
| Mendonça, A | 1 |
| Tavora, MZ | 1 |
| da Silva, RM | 1 |
| Hara, VM | 1 |
| Portugal, OP | 1 |
| Martinez Filho, EE | 1 |
| Brignole, M | 1 |
| Gianfranchi, L | 1 |
| Menozzi, C | 1 |
| Raviele, A | 1 |
| Oddone, D | 1 |
| Lolli, G | 1 |
| Bottoni, N | 1 |
| Markel, ML | 1 |
| Miles, WM | 1 |
| Luck, JC | 1 |
| Klein, LS | 1 |
| Prystowsky, EN | 1 |
| Brodsky, MA | 1 |
| Orlov, MV | 1 |
| Allen, BJ | 1 |
| Orlov, YS | 1 |
| Wolff, L | 1 |
| Winters, R | 1 |
| Niebauer, M | 1 |
| Daoud, E | 1 |
| Goyal, R | 3 |
| Chan, KK | 1 |
| Harvey, M | 1 |
| Bogun, F | 1 |
| Castellani, M | 1 |
| Man, KC | 3 |
| Strickberger, SA | 3 |
| Morady, F | 3 |
| Lee, KL | 1 |
| Lauer, MR | 1 |
| Young, C | 1 |
| Lai, WT | 1 |
| Tai, YT | 1 |
| Chun, H | 1 |
| Liem, LB | 1 |
| Sung, RJ | 1 |
| Behboodikhah, M | 1 |
| Brembilla-Perrot, B | 2 |
| Houplon, P | 2 |
| Jacquemin, L | 2 |
| Lemoine, C | 1 |
| Mathieu, P | 1 |
| de Meester, A | 1 |
| Chaudron, JM | 1 |
| de Roy, L | 1 |
| Takahashi, K | 1 |
| Kitazawa, H | 2 |
| Shibata, A | 2 |
| Houriez, P | 1 |
| Beurrier, D | 1 |
| Berder, V | 1 |
| Terrier de la Chaise, A | 1 |
| Louis, P | 1 |
| Mukhopadhyay, PS | 1 |
| Syed, ZA | 1 |
| Knight, BP | 1 |
| Bahu, M | 1 |
| Weiss, R | 1 |
| Daoud, EG | 1 |
| Song, Y | 1 |
| Shryock, JC | 1 |
| Belardinelli, L | 1 |
| Naitoh, N | 2 |
| Furushima, H | 1 |
| Ohira, K | 1 |
| Taneda, K | 1 |
| Yamaura, M | 2 |
| Tagawa, M | 1 |
| Niwano, S | 2 |
| Tsuchida, K | 1 |
| Yoshizawa, N | 1 |
| Moriguchi, M | 1 |
| Kitano, Y | 1 |
| Izumi, T | 1 |
| Fisher, JD | 1 |
| Krikler, D | 1 |
| Hallidie-Smith, KA | 1 |
| Kou, WH | 1 |
| Gainullin, RZ | 1 |
| Steinberg, SF | 1 |
| Danilo, P | 1 |
| Suzuki, H | 1 |
| Torigoe, K | 1 |
| Numata, O | 1 |
| Yazaki, S | 1 |
| Yazawa, T | 1 |
| Adachi, T | 1 |
| Ryu, S | 1 |
| Asano, T | 1 |
| Obara, C | 1 |
| Han, W | 1 |
| Wang, Z | 1 |
| Nattel, S | 1 |
| Lahat, H | 1 |
| Levy-Nissenbaum, E | 1 |
| Bahan, T | 1 |
| Friedman, E | 1 |
| Khoury, A | 1 |
| Kastner, DL | 1 |
| Goldman, B | 1 |
| Pras, E | 1 |
| DeLacey, WA | 1 |
| Nath, S | 1 |
| Haines, DE | 1 |
| Barber, MJ | 1 |
| DiMarco, JP | 1 |
| Chavernac, P | 1 |
| Le Métayer, P | 1 |
| Barat, JL | 1 |
| Montserrat, P | 1 |
| Héraudeau, A | 1 |
| Warin, JF | 1 |
| Kuwano, H | 1 |
| Hosono, H | 1 |
| Kusano, Y | 1 |
| Naitho, N | 1 |
| Tamura, M | 1 |
| Wiesfeld, AC | 1 |
| Crijns, HJ | 1 |
| Van Veldhuisen, DJ | 1 |
| Van Gilst, WH | 1 |
| Lie, KI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia[NCT03042078] | 3,060 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for isoproterenol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Effect of isoproterenol on accessory pathways without overt retrograde conduction.
Topics: Accessory Nerve; Adolescent; Adult; Aged; Atrioventricular Node; Bundle of His; Electrocardiography; | 1995 |
The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Topics: Action Potentials; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Ele | 1994 |
107 other studies available for isoproterenol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Electrophysiology and Arrhythmogenesis in the Human Right Ventricular Outflow Tract.
Topics: Acetylcholine; Adrenergic Agents; Cardiac Electrophysiology; Cholinergic Agents; Electrocardiography | 2022 |
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Heart Arrest; Humans; Isoprot | 2022 |
Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Calcium-Calmodulin-Dependent Protein | 2020 |
Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Case | 2018 |
Primary Ventricular Fibrillation in a Patient with Mild Hypercalcemia.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hypercalcemia; Hyperparathyroidi | 2018 |
Ventricular tachycardia in a 16-year-old boy with primary hyperparathyroidism.
Topics: Adolescent; Adrenergic beta-Agonists; Calcium; Electrocardiography; Humans; Hypercalcemia; Hyperpara | 2018 |
β1-Adrenoceptor blocker aggravated ventricular arrhythmia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aminophylline; Female; Huma | 2013 |
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2013 |
Autonomic modulation of repolarization instability in patients with heart failure prone to ventricular tachycardia.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aged; Autonomic | 2013 |
Monomorphic sustained ventricular tachycardia late after arterial switch for d-transposition of the great arteries: ablation in the sinus of valsalva.
Topics: Adolescent; Atropine; Cardiac Pacing, Artificial; Catheter Ablation; Coronary Vessel Anomalies; Elec | 2013 |
Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.
Topics: Action Potentials; Animals; Calmodulin; Gene Knock-In Techniques; Isoproterenol; Mice; Myocytes, Car | 2014 |
Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiac Pacing, Artificial; Cardiomegaly; Cells, Culture | 2014 |
Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Heart; Heterozygote; Homozygote; Humans; Isoproterenol; Mice | 2015 |
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gen | 2015 |
A stepwise approach to the induction of idiopathic fascicular ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Atropine; Cardiotonic Agents; Catheter Ablation; Electric Stimulation; Elec | 2015 |
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Topics: Base Sequence; Caffeine; Calcium Signaling; Calsequestrin; Cell Differentiation; Genotyping Techniqu | 2015 |
Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Electrocardiography; El | 2015 |
Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.
Topics: Animals; Calcium; Calcium-Binding Proteins; Calsequestrin; Disease Models, Animal; Echocardiography; | 2015 |
R4496C RyR2 mutation impairs atrial and ventricular contractility.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Calcium Signaling; Heart Atria; He | 2016 |
Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Calcium Signaling; Case-Control Studies; Electro | 2016 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sud | 2016 |
Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
Topics: Action Potentials; Adult; Animals; Anti-Asthmatic Agents; Calcium; Calreticulin; Calsequestrin; Cell | 2016 |
A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.
Topics: Adenine; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiotonic Agents; Electric Cou | 2017 |
Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Benzylamines; Calcium Signaling; Calcium-Calmo | 2008 |
Monomorphic ventricular tachycardia in 'Brugada syndrome': clinical case and literature review.
Topics: Adrenergic beta-Agonists; Adult; Brugada Syndrome; Electrocardiography; Follow-Up Studies; Heart Rat | 2008 |
The utility of ketamine in facilitating the induction of isoproterenol-refractory idiopathic ventricular tachyarrhythmias.
Topics: Drug Synergism; Electrocardiography; Female; Humans; Isoproterenol; Ketamine; Tachycardia, Ventricul | 2009 |
Irregular tachycardia: what is the mechanism? Part I.
Topics: Cardiotonic Agents; Diagnosis, Differential; Electrocardiography; Humans; Isoproterenol; Tachycardia | 2009 |
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
Topics: Adrenergic beta-Agonists; Animals; Caffeine; Calcium Signaling; Cardiac Pacing, Artificial; Catechol | 2009 |
Double fire or junctional ectopy?
Topics: Cardiotonic Agents; Diagnosis, Differential; Electrocardiography; Humans; Isoproterenol; Tachycardia | 2009 |
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
Topics: Animals; Caffeine; Calcium Signaling; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Disease | 2010 |
Ventricular tachycardia complicating head-up tilt test: the role of coronary artery spasm.
Topics: Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiopulmonary Resuscitation; Cardiotoni | 2011 |
In the RyR2(R4496C) mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves.
Topics: Adrenergic Agents; Animals; Calcium; Calcium Signaling; Disease Models, Animal; Isoproterenol; Mice; | 2010 |
Arrhythmia and sudden death associated with elevated cardiac chloride channel activity.
Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Block; Atrioventricular Node; Bradycardia; Cardiac P | 2011 |
Wolff-Parkinson-White syndrome and isoproterenol testing in children: a valid adjunct to predict risk?
Topics: Adolescent; Cardiac Catheterization; Cardiotonic Agents; Catheter Ablation; Child; Child, Preschool; | 2011 |
Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Signaling; Disease Models, Animal; Extracellular Space; Fle | 2011 |
A new method for induction of atrioventricular nodal reentrant tachycardia in non-inducible cases.
Topics: Adult; Atropine; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studie | 2011 |
Idiopathic ventricular tachycardia originating from the posteroseptal mitral annulus: a case report.
Topics: Adenosine Triphosphate; Aged; Cardiotonic Agents; Catheter Ablation; Cyclic AMP; Exercise; Humans; I | 2006 |
Dual ventricular response: what is the mechanism?
Topics: Action Potentials; Adrenergic beta-Agonists; Cardiac Pacing, Artificial; Catheter Ablation; Electroc | 2012 |
Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
Topics: Animals; Calcium; Calcium Signaling; Calsequestrin; Cardiac Pacing, Artificial; Cardiotonic Agents; | 2012 |
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Adult; Calcium; Calcium Signaling; Calsequestrin; Cell Differentiation; Ch | 2012 |
Focal initiation of sustained and nonsustained ventricular tachycardia in a canine model of ischemic cardiomyopathy.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiomyopathies; | 2012 |
Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Animals; Calcium; Calcium Signaling; Disea | 2012 |
Effect of isoprenaline chronic stimulation on APD restitution and ventricular arrhythmogenesis.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiomegaly; Card | 2013 |
High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Arrhythmogenic Right Ventricular Dysplasia; Balti | 2013 |
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
Topics: Adult; Animals; Atropine; Bradycardia; Caffeine; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2013 |
Electrophysiological consequences of human IKs channel expression in adult murine heart.
Topics: Adrenergic beta-Agonists; Aging; Animals; Blood Pressure; Cardiac Pacing, Artificial; Delayed Rectif | 2003 |
Adrenergic nervous system influences on the induction of ventricular tachycardia.
Topics: Adrenergic beta-Agonists; Adult; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Iso | 2002 |
Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts: influences of cardiac hypertrophy and isoproterenol.
Topics: Animals; Arrhythmias, Cardiac; Cardiomegaly; Drug Synergism; Heart Block; Humans; In Vitro Technique | 2002 |
Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Topics: Action Potentials; Anesthesia; Animals; Blood Pressure; Calcium; Cardiomyopathy, Hypertrophic, Famil | 2003 |
Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Caffeine; Calcium; Cell Line; Cresols; Humans; Isoprote | 2003 |
Heterogeneous ventricular repolarization provides a substrate for arrhythmias in a German shepherd model of spontaneous arrhythmic death.
Topics: Action Potentials; Animals; Cells, Cultured; Death, Sudden, Cardiac; Dogs; Electric Conductivity; He | 2003 |
Prevention of ventricular tachycardia and fibrillation by intravenous isoproterenol and epinephrine.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Epinephrine; Heart Block; | 1963 |
THE TREATMENT OF PAROXYSMAL VENTRICULAR TACHYCARDIA WITH ISOPROTERENOL.
Topics: Electrocardiography; Infusions, Parenteral; Isoproterenol; Procainamide; Quinidine; Tachycardia; Tac | 1964 |
[PAROXYSMAL VENTRICULAR TACHYCARDIA WITH HEART BLOCK].
Topics: Heart Block; Isoproterenol; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventric | 1964 |
[TREATMENT OF VENTRICULAR TACHYCARDIA WITH ALUPENT].
Topics: Drug Therapy; Electrocardiography; Isoproterenol; Metaproterenol; Myocardial Infarction; Procainamid | 1965 |
PREVENTION OF VENTRICULAR TACHYCARDIA AND STOKES-ADAMS SEIZURES IN COMPLETE HEART BLOCK; TREATMENT WITH LARGE DOSES OF INTRAVENOUS ISOPROTERENOL.
Topics: Adams-Stokes Syndrome; Atrial Fibrillation; Drug Therapy; Electrocardiography; Geriatrics; Heart Blo | 1965 |
Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium-Transporting ATPases; Cell Line; Cyclic AMP-Depend | 2004 |
Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts.
Topics: Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Cytoso | 2004 |
Cellular mechanism of calcium-mediated triggered activity in the heart.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium; Calcium Channels; Calcium Signaling; | 2005 |
A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
Topics: Adrenergic beta-Agonists; Adult; Exercise Test; Humans; Isoproterenol; Male; Mutation, Missense; Pol | 2005 |
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
Topics: Action Potentials; Animals; Caffeine; Calcium; Catecholamines; Disease Models, Animal; Dogs; Dose-Re | 2005 |
The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Electrocardiography; Female; Humans; Isoprote | 2005 |
Frequency of spontaneous and inducible atrioventricular nodal reentry tachycardia in patients with idiopathic outflow tract ventricular arrhythmias.
Topics: Adolescent; Cardiac Pacing, Artificial; Catheter Ablation; Chi-Square Distribution; Electrocardiogra | 2006 |
[Catecholaminergic polymorphic ventricular tachycardia successfully treated by beta blocker].
Topics: Adolescent; Adrenergic beta-Antagonists; Catecholamines; Female; Humans; Isoproterenol; Propranolol; | 2006 |
Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).
Topics: Adolescent; Adult; Catecholamines; Electrocardiography; Electrophysiologic Techniques, Cardiac; Exer | 2006 |
A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Topics: Animals; Caffeine; Calcium; Calcium Signaling; Calsequestrin; Cardiotonic Agents; Death, Sudden, Car | 2007 |
Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium; Calcium Channels, L-Type; Calsequestr | 2007 |
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Impl | 2007 |
Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Topics: Animals; Calbindin 2; Calcium; Calcium Channels; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2007 |
Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract.
Topics: Adenosine Triphosphate; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheter Ablation; Electrophysio | 2007 |
Linking calsequestrin to lumenal control of SR Ca2+ release.
Topics: Animals; Calbindin 2; Calcium; Calcium Channels; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2007 |
Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Adult; Arrhythmia, Sinus; Cardiac Electrophysiology; Cardiotonic Agents; Child; Electroc | 2007 |
Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2008 |
Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Signaling; Cardiac Pacing, Artificial; | 2008 |
Inducible ventricular tachyarrhythmia in children with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Age Factors; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Child; Chi | 1994 |
Sustained left ventricular tachycardia terminated by dipyridamole: cyclic AMP-mediated triggered activity as a possible mechanism.
Topics: Acetylcholine; Adolescent; Cardiac Complexes, Premature; Cyclic AMP; Dipyridamole; Electrocardiograp | 1994 |
Comparison of spectral temporal mapping to the time domain signal-averaged electrocardiogram in normal subjects and in patients with coronary artery disease and sustained ventricular tachycardia.
Topics: Action Potentials; Adult; Bundle-Branch Block; Cardiac Pacing, Artificial; Coronary Disease; Electro | 1994 |
Idiopathic left ventricular tachycardia: new insights into electrophysiological characteristics and radiofrequency catheter ablation.
Topics: Adult; Bundle-Branch Block; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography; Elec | 1995 |
The effects of adenosine on idiopathic ventricular tachycardia.
Topics: Adenosine Triphosphate; Adolescent; Adult; Bundle-Branch Block; Child; Electrocardiography; Exercise | 1994 |
[Catheter ablation of tachycardia of the outlet right ventricle using radiofrequency as power source].
Topics: Adult; Catheter Ablation; Electrocardiography; Female; Follow-Up Studies; Humans; Isoproterenol; Mid | 1993 |
Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Autonomic Nervous System; Blood Pressure; Cardiac Pacing, Artificial; Car | 1993 |
Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiac Pacing, Artificial; Drug Therapy, Comb | 1993 |
Clinical assessment of adrenergic tone and responsiveness to beta-blocker therapy in patients with symptomatic ventricular tachycardia and no apparent structural heart disease.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Aged; C | 1996 |
Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Disease; Fema | 1996 |
Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease.
Topics: Adenosine; Adult; Bundle-Branch Block; Catecholamines; Electrocardiography; Female; Heart Conduction | 1996 |
Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
Topics: Action Potentials; Administration, Oral; Adrenergic beta-Agonists; Analysis of Variance; Anti-Arrhyt | 1996 |
[Should protocol of programmed ventricular stimulation be adapted to each patient? ].
Topics: Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Disease; Electrocardiography; Follow-Up Stu | 1996 |
Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Pacing, Artificial; E | 1997 |
Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablation; Electric Stimulation | 1997 |
Increased atrial vulnerability in arrhythmogenic right ventricular disease.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Diagnosis, Differential; Di | 1998 |
Effect of isoproterenol on QRS complex morphology during ventricular pacing: implications for pace mapping.
Topics: Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablation; Electrocardiography; Female | 1998 |
Potentiating effect of acetylcholine on stimulation by isoproterenol of L-type Ca2+ current and arrhythmogenic triggered activity in guinea pig ventricular myocytes.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Calcium Channels; Calcium Channels, L-Type; Drug S | 1998 |
Use-dependent electrophysiologic effects of DL-sotalol and modulation by isoproterenol in the human ventricle.
Topics: Action Potentials; Adult; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Drug Interactions; Elect | 1998 |
A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiograph | 1998 |
AV reentrant and idiopathic ventricular double tachycardias: complicated interactions between two tachycardias.
Topics: Adrenergic beta-Antagonists; Catheter Ablation; Humans; Isoproterenol; Male; Middle Aged; Tachycardi | 1999 |
Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Follow-Up Studies; Hum | 1999 |
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; An | 1999 |
Interaction between autonomic tone and the negative chronotropic effect of adenosine in humans.
Topics: Adenosine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; | 1999 |
beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Anim | 2000 |
Infant case with a malignant form of Brugada syndrome.
Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Atropine; Drug Therapy, Combination; Electrocardio | 2000 |
Ventricular arrhythmias with left bundle branch block pattern and inferior axis: assessment of their mechanisms on the basis of response to ATP, nicorandil and verapamil.
Topics: Adenosine Triphosphate; Adult; Anti-Arrhythmia Agents; Biological Transport, Active; Bundle-Branch B | 2000 |
Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells.
Topics: Acetamides; Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Benzodiaze | 2001 |
Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Arabs; Bradycardia; Catecholamine | 2001 |
Adenosine and verapamil-sensitive ventricular tachycardia originating from the left ventricle: radiofrequency catheter ablation.
Topics: Adenosine; Bundle-Branch Block; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography; | 1992 |
[Complementary value of the isoprenaline test and high-amplification ECG in the diagnosis of arrhythmogenic dysplasia of the right ventricle].
Topics: Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Ventricles; Huma | 1992 |
Successful radiofrequency current catheter ablation of sustained ventricular tachycardia.
Topics: Aged; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography; Heart Conduction System; H | 1992 |
Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.
Topics: Aged; Cardiac Pacing, Artificial; Electric Stimulation; Electrocardiography; Exercise Test; Female; | 1992 |